Genetic links seen for HDL cholesterol, systolic BP with Alzheimer’s disease
May 17, 2023
Genetically determined high-density lipoprotein cholesterol and systolic blood pressure were linked to increased odds of Alzheimer’s disease.
Incidence of new-onset HTN higher for COVID-19 versus influenza patients
Aug 21, 2023
Hospitalized and nonhospitalized patients with COVID-19 were more likely to develop persistent hypertension than those with influenza.
Preeclampsia linked to increased risk for young-onset dementia
May 31, 2024
An even higher risk for young-onset dementia was seen for preeclampsia before 34 weeks of gestation or superimposed on chronic hypertension.
Risk for dementia reduced in association with antihypertensive use
Sep 13, 2023
An individual patient data meta-analysis shows increased risk for dementia for those with untreated hypertension.
Prevalence of risk factors for Alzheimer’s, related dementias identified
May 20, 2022
The highest prevalence seen for high blood pressure and not meeting aerobic physical activity guidelines, followed by obesity.
Accelerated trajectory of CV risk predicts dementia risk
Apr 21, 2022
Those with an accelerated versus stable cardiovascular risk trajectory have an increased risk for memory decline.
Hypertension linked to increased risk for severe COVID-19
Nov 10, 2022
Elevated systolic blood pressure showed a dose-response relationship with severe COVID-19 for those taking antihypertensive meds.
Hypertension linked to hospitalization for omicron in vaccinated persons
Aug 09, 2022
The findings were seen among individuals who received at least three mRNA vaccine doses and in whom COVID-19 subsequently was diagnosed during omicron surge.
Prior statin use linked to reduced risk for death in COVID-19
Jul 21, 2021
The risk for death was significantly reduced with prior statin and/or antihypertensive use among those with a history of cardiovascular and/or hypertension.
Polypill not linked to reduced cognitive decline in seniors
Jan 30, 2023
But a polypill with or without aspirin is associated with reduced functional decline for those aged 65 years or older with cardiovascular risk factors.